KR20120117788A - 국소용 폼 조성물 - Google Patents

국소용 폼 조성물 Download PDF

Info

Publication number
KR20120117788A
KR20120117788A KR1020127016200A KR20127016200A KR20120117788A KR 20120117788 A KR20120117788 A KR 20120117788A KR 1020127016200 A KR1020127016200 A KR 1020127016200A KR 20127016200 A KR20127016200 A KR 20127016200A KR 20120117788 A KR20120117788 A KR 20120117788A
Authority
KR
South Korea
Prior art keywords
composition
rifaximin
rectal
weight
acid
Prior art date
Application number
KR1020127016200A
Other languages
English (en)
Korean (ko)
Inventor
아마르 룰라
지나 말호트라
Original Assignee
시플라 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 시플라 리미티드 filed Critical 시플라 리미티드
Publication of KR20120117788A publication Critical patent/KR20120117788A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
KR1020127016200A 2009-11-23 2010-11-23 국소용 폼 조성물 KR20120117788A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2703/MUM/2009 2009-11-23
IN2703MU2009 2009-11-23

Publications (1)

Publication Number Publication Date
KR20120117788A true KR20120117788A (ko) 2012-10-24

Family

ID=43447946

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020127016200A KR20120117788A (ko) 2009-11-23 2010-11-23 국소용 폼 조성물

Country Status (12)

Country Link
EP (1) EP2503989A2 (ru)
JP (1) JP2013511570A (ru)
KR (1) KR20120117788A (ru)
CN (1) CN102724960A (ru)
AU (1) AU2010320656B2 (ru)
BR (1) BR112012012316A2 (ru)
CA (1) CA2781580A1 (ru)
MX (1) MX2012005883A (ru)
NZ (1) NZ600362A (ru)
RU (1) RU2012126084A (ru)
WO (1) WO2011061519A2 (ru)
ZA (1) ZA201204018B (ru)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI1698630T1 (sl) 2005-03-03 2015-01-30 Alfa Wassermann S.P.A. Nove polimorfne oblike rifaksimina, postopki za njihovo pripravo in njihova uporaba v medicinskih pripravkih
ITBO20050123A1 (it) 2005-03-07 2005-06-06 Alfa Wassermann Spa Formulazioni farmaceutiche gastroresistenti contenenti rifaximina
JP5042209B2 (ja) 2005-03-24 2012-10-03 ノーラブズ エービー 酸化窒素による美容治療、前記治療を実施する装置、及びその製造方法
BR112012003792B1 (pt) 2009-08-21 2020-05-19 Novan Inc composição tópica, e, uso da composição tópica
IT1398550B1 (it) 2010-03-05 2013-03-01 Alfa Wassermann Spa Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo
WO2013006608A1 (en) 2011-07-05 2013-01-10 Novan, Inc. Topical compositions
ITBO20110461A1 (it) 2011-07-29 2013-01-30 Alfa Wassermann Spa Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali.
BR112014021501B1 (pt) * 2012-03-14 2020-12-08 Novan, Inc composição farmacêutica para administração tópica de um ingrediente farmacêutico ativo ativado por umidade
ITBO20120368A1 (it) 2012-07-06 2014-01-07 Alfa Wassermann Spa Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso.
US9855211B2 (en) 2013-02-28 2018-01-02 Novan, Inc. Topical compositions and methods of using the same
CA2920110C (en) 2013-08-08 2022-05-31 Novan, Inc. Compositions and kits including a nitric oxide releasing compound and a hydrogel
PL3546464T3 (pl) 2014-05-12 2020-11-02 Alfasigma S.P.A. Sposób wytwarzania i zastosowanie postaci krystalicznej Tau rifaksyminy solwatowanej z DEGME
EP3177262A4 (en) 2014-08-08 2018-04-18 Novan Inc. Topical emulsions
US10912743B2 (en) 2016-03-02 2021-02-09 Novan, Inc. Compositions for treating inflammation and methods of treating the same
EP3442502A4 (en) 2016-04-13 2019-11-06 Novan, Inc. COMPOSITIONS, SYSTEMS, KITS AND METHODS FOR TREATING INFECTION
EP3554473A1 (en) * 2016-12-16 2019-10-23 Ferring B.V. Rectal foam formulations
CN112165935A (zh) 2018-03-01 2021-01-01 诺万公司 一氧化氮释放性栓剂及其使用方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2907118A1 (de) 1979-02-20 1980-09-04 Schering Ag Neue prostacyclin-derivate und verfahren zu ihrer herstellung
IT1154655B (it) 1980-05-22 1987-01-21 Alfa Farmaceutici Spa Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica
IT1199374B (it) 1984-05-15 1988-12-30 Alfa Farmaceutici Spa Processo per la preparazione di pirido-imidazo-rifamicine
GB8909559D0 (en) 1989-04-26 1989-06-14 Smith Kline French Lab Pharmaceutical compositions
FR2647344B1 (fr) 1989-05-25 1995-06-02 Physiopharm Sarl Mousse aerosol a usage rectal
US4946939A (en) 1989-05-30 1990-08-07 The Dow Chemical Company High purity polyether polyols
IT1243379B (it) 1990-07-27 1994-06-10 Giuliani Spa Composizione farmaceutica adatta alla somministrazione rettale di principi attivi che esplicano un'azione di medicazione a livello del colon prevalentemente di tipo topico
IT1253711B (it) * 1991-12-17 1995-08-23 Alfa Wassermann Spa Formulazioni farmaceutiche vaginali contenenti rifaximin e loro uso nel trattamento delle infezioni vaginali
IT1264494B1 (it) 1993-03-23 1996-09-24 Alfa Wassermann Spa Uso di rifaximin e di formulazioni che la contengono nel trattamento delle dispepsie gastriche originate da helicobacter
IT1290679B1 (it) 1997-02-14 1998-12-10 Alfa Wassermann Spa Uso della rifaximina e delle composizioni farmaceutiche che la contengono nel trattamento della diarrea da criptosporidiosi.
US20070292461A1 (en) * 2003-08-04 2007-12-20 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US7820145B2 (en) * 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
ITMI20032144A1 (it) 2003-11-07 2005-05-08 Alfa Wassermann Spa Forme polimorfe di rifaximina, processi per ottenerle e
SI1698630T1 (sl) 2005-03-03 2015-01-30 Alfa Wassermann S.P.A. Nove polimorfne oblike rifaksimina, postopki za njihovo pripravo in njihova uporaba v medicinskih pripravkih
CN101594885B (zh) * 2006-03-09 2017-07-18 萨利克斯药品公司 利福昔明抗直肠功能障碍制剂
WO2009137672A1 (en) * 2008-05-07 2009-11-12 Salix Pharmaceuticals, Ltd. Methods of treating bowel disease by administering a bowel cleanser and an antibiotic
CN101502510B (zh) * 2009-03-19 2011-11-09 山东京卫制药有限公司 一种用于治疗阴道炎症的药物组合物及其制备方法

Also Published As

Publication number Publication date
MX2012005883A (es) 2012-10-09
AU2010320656A1 (en) 2012-06-21
CA2781580A1 (en) 2011-05-26
WO2011061519A3 (en) 2011-10-06
ZA201204018B (en) 2012-12-27
RU2012126084A (ru) 2013-12-27
CN102724960A (zh) 2012-10-10
WO2011061519A2 (en) 2011-05-26
JP2013511570A (ja) 2013-04-04
AU2010320656B2 (en) 2015-07-30
NZ600362A (en) 2014-08-29
EP2503989A2 (en) 2012-10-03
BR112012012316A2 (pt) 2016-04-26

Similar Documents

Publication Publication Date Title
AU2010320656B2 (en) Topical foam composition
EP2964196A1 (en) Pharmaceutical compositions for rectal administration
KR20120099731A (ko) 국소용 폼 조성물
KR101398648B1 (ko) 리팍시민 직장 기능장애 치료 제제
WO2012076832A1 (en) Suppositories comprising rifaximin
EP2560614B1 (en) Pharmaceutical compositions and methods for administering the same
CA3194409A1 (en) Cannabinoid-containing compositions and use for treating and preventing diseases
US20150196488A1 (en) Topical Foam Composition
US20090176719A1 (en) Compositions and methods for treating perioral dermatitis
KR20150136081A (ko) 직장 투여용 약학 조성물
AU2013270516A1 (en) Rifaximin anti-rectal dysfunction preparation

Legal Events

Date Code Title Description
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid